| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 376.40B | 401.90B | 321.68B | 328.96B | 436.39B |
| Gross Profit | 376.40B | 401.84B | 321.67B | 301.03B | 406.09B |
| EBITDA | 68.52B | 60.21B | 314.87B | 320.92B | 38.77B |
| Net Income | 52.12B | 44.96B | 27.26B | 37.38B | 26.83B |
Balance Sheet | |||||
| Total Assets | 3.15T | 2.83T | 2.34T | 2.18T | 1.95T |
| Cash, Cash Equivalents and Short-Term Investments | 77.49B | 29.36B | 30.93B | 748.22B | 677.93B |
| Total Debt | 243.44B | 13.01B | 13.38B | 12.72B | 13.10B |
| Total Liabilities | 2.81T | 2.52T | 2.08T | 1.94T | 1.71T |
| Stockholders Equity | 302.27B | 291.42B | 249.59B | 228.45B | 226.74B |
Cash Flow | |||||
| Free Cash Flow | 258.31B | 150.53B | 133.88B | 138.81B | 104.72B |
| Operating Cash Flow | 262.49B | 154.40B | 137.86B | 147.91B | 108.41B |
| Investing Cash Flow | -251.64B | -209.90B | -161.36B | -168.98B | -66.09B |
| Financing Cash Flow | 35.74B | 61.34B | 3.29B | 28.48B | -31.37B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$1.04T | 4.51 | 31.07% | 3.42% | 17.69% | 126.41% | |
71 Outperform | HK$389.47B | 9.89 | 18.91% | 3.28% | 15.08% | 23.13% | |
70 Outperform | HK$75.91B | 2.48 | 29.19% | 1.81% | 23.64% | 36.32% | |
70 Outperform | HK$322.74B | 8.31 | 14.21% | 3.77% | 6.42% | 66.35% | |
70 Outperform | HK$189.23B | 4.31 | 38.67% | 5.24% | 49.90% | 203.77% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | HK$1.14T | 8.07 | 14.77% | 4.25% | 10.20% | 19.74% |